glp 1 for ulcerative colitis GLP-1 Receptor Agonists in Obese Patients with Inflammatory Bowel Disease: from Molecular Mechanisms to Clinical Considerations and Practical Recommendations Safe and Effective Use | Current Obesity Reports GLP-1R Agonists and Their Therapeutic

CrossRef Cause of death and cause-specific mortality for primary liver cancer in South Korea: A nationwide population-based study in hepatitis B virus-endemic area Bo Hyun Kim, Dahhay Lee, Kyu-Won Jung, Young-Joo Won, Hyunsoon Cho Clinical and Molecular Hepatology.2022

For the treatment of obesity, GLP-1RAs and GIP/ GLP-1RAs are indicated in patients with a body mass index (BMI) 30 kg m 2 , or 27 kg m 2 in the presence of at least one weight-related comorbidity, to support weight reduction [23]

doi: 10.1056/NEJMoa2028395 194 FangXDuZDuanCZhanSWangTZhuMet al

Enhanced Fat Metabolism: These peptides aid in breaking down body fat by increasing the metabolic rate and promoting lipolysis (fat breakdown)